249 related articles for article (PubMed ID: 17192959)
1. Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.
Halin S; Hammarsten P; Wikström P; Bergh A
Prostate; 2007 Mar; 67(4):370-7. PubMed ID: 17192959
[TBL] [Abstract][Full Text] [Related]
2. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
3. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration.
Lekås E; Johansson M; Widmark A; Bergh A; Damber JE
Urol Res; 1997; 25(5):309-14. PubMed ID: 9373910
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
Wikström P; Lindahl C; Bergh A
Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
[TBL] [Abstract][Full Text] [Related]
5. Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.
Wikström P; Ohlson N; Stattin P; Bergh A
Prostate; 2007 Sep; 67(12):1277-84. PubMed ID: 17597113
[TBL] [Abstract][Full Text] [Related]
6. Changes in the androgen levels in the ventral prostate of spontaneously hypertensive rats after castration.
Hu M; Xin D; Chen J; Sun G; Wang Y; Na Y
BJU Int; 2009 Aug; 104(3):406-11. PubMed ID: 19239443
[TBL] [Abstract][Full Text] [Related]
7. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
8. Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age.
Banerjee S; Banerjee PP; Brown TR
Endocrinology; 2000 Feb; 141(2):821-32. PubMed ID: 10650965
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft.
Kim D; Gregory CW; French FS; Smith GJ; Mohler JL
Am J Pathol; 2002 Jan; 160(1):219-26. PubMed ID: 11786415
[TBL] [Abstract][Full Text] [Related]
10. Remodeling of rat ventral prostate after castration involves heparanase-1.
Augusto TM; Felisbino SL; Carvalho HF
Cell Tissue Res; 2008 May; 332(2):307-15. PubMed ID: 18278514
[TBL] [Abstract][Full Text] [Related]
11. Prostate adenocarcinoma: effects of castration on in situ androgen uptake by individual cell types.
Lippert MC; Keefer DA
J Urol; 1987 Jan; 137(1):140-5. PubMed ID: 3795357
[TBL] [Abstract][Full Text] [Related]
12. Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats.
Johansson A; Rudolfsson SH; Wikström P; Bergh A
Endocrinology; 2005 Aug; 146(8):3463-70. PubMed ID: 15845622
[TBL] [Abstract][Full Text] [Related]
13. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
[TBL] [Abstract][Full Text] [Related]
14. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
15. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
16. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
17. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
18. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of androgen receptors in the separate rat prostate lobes: androgen independent expression in the lateral lobe.
Prins GS
J Steroid Biochem; 1989 Sep; 33(3):319-26. PubMed ID: 2779222
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death.
Kyprianou N; Isaacs JT
Mol Endocrinol; 1989 Oct; 3(10):1515-22. PubMed ID: 2608047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
